CEACAM1 and melanoma: There is a study suggesting that CEACAM1, particularly the CEACAM1-3S isoform, was able to induce enhanced expression of the NKG2D ligands MICA and ULBP2 on the surface of melanoma cells, which in turn contributed to NK cell-mediated cytolysis of tumor cells [38].